Sign up Australia
Proactive Investors - Run By Investors For Investors

The Hydroponics Company advances medical cannabis strategy as shares released from escrow

The company has a clear strategy for bringing medicinal cannabis to the Australian market.
The Hydroponics Company advances medical cannabis strategy as shares released from escrow
The company has $4.7 million in cash

The Hydroponics Company Ltd (ASX:THC) has been a medical cannabis success story since listing on the ASX in May this year, following an IPO at an entry price of $0.20.

Adding further value to the IPO, for each two shares subscribed and issued, there was one $0.40 option given, which is now heavily in-the-money.

The Hydroponics Company last traded at $0.85, and has been as high as $1.15.

The company has now allocated additional shares which have exited escrow, with circa 104 million on issue.

Total shareholders in the company has now swelled towards 2000, a more than two-fold increase on the IPO entrants.

Key achievements since listing

The company's wholly-owned subsidiary, Canndeo Limited, has delivered key milestones since listing, such as:

- International Partner Alliance agreement;
- Medicinal Cannabis Research Licence Granted July 2017;
- Clinical Trial partner mandated;
- Medicinal Cannabis Prescription and Dispensing Portal;
- Medicinal Cannabis Licence granted October 2017;
- Manufacturing Licence application lodged; and
- Significant investment into Australian facilities.

View full THC profile View Profile

The Hydroponics Company Timeline

Related Articles

test tubes
January 23 2018
Under former chief executive Peter George and his successor Shaun Chilton, it has been transformed via a series of well-judged, quickly integrated and, crucially, cash generative acquisitions
mri scanner
June 06 2018
It is actively supporting the hunt for breakthrough treatments for Alzheimer’s, Parkinson’s, Huntington’s and multiple sclerosis
DNA sequence
July 12 2018
The cell therapy specialist also reported there had been industry interest around its main programmes

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use